Evidence map›Paper›PMID 32244972›Full record

ReviewJournal of clinical medicine2020

Ischemia-Reperfusion Injury in Marginal Liver Grafts and the Role of Hypothermic Machine Perfusion: Molecular Mechanisms and Clinical Implications.

Zoltan Czigany, Isabella Lurje, Moritz Schmelzle, Wenzel Schöning, Robert Öllinger, Nathanael Raschzok, Igor M Sauer, Frank Tacke, Pavel Strnad, Christian Trautwein and 6 more

Registry-linked trialAbstract readReview
In one paragraph

Review in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07595627 (Prospective and Randomized Clinical Study of the Effect of Hypothermic Machine Perfusion on Liver Graft Preservation), which is not on this map. Cited by 65 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07595627 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Prospective and Randomized Clinical Study of the Effect of Hypothermic Machine Perfusion on Liver Graft Preservation

TypeinterventionalSponsorUniversity of Sao Paulo General HospitalRan2026 to 2028Enrolled40ConditionsLiver Transplant, Liver FailureArmsHypothermic Machine Perfusion, Static Cold Storage
3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Biliary Viability Assessment and Treatment Options of Biliary Injury During Normothermic Liver Perfusion-A Systematic Review.Transplant international : official journal of the European Society for Organ Transplantation · 2022
    Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Advancements inFrontiers in transplantation · 2026
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. [Innovations in transplantation medicine].Innere Medizin (Heidelberg, Germany) · 2025
    Review
  18. Review
  19. Article
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Zoltan CziganyDepartment of Surgery and Transplantation, University Hospital RWTH Aachen, 52074 Aachen, Germany.ORCID 0000-0003-0373-3210
Isabella LurjeDepartment of Surgery, Campus Charité Mitte | Campus Virchow-Klinikum-Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.
Moritz SchmelzleDepartment of Surgery, Campus Charité Mitte | Campus Virchow-Klinikum-Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.
Wenzel SchöningDepartment of Surgery, Campus Charité Mitte | Campus Virchow-Klinikum-Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.
Robert ÖllingerDepartment of Surgery, Campus Charité Mitte | Campus Virchow-Klinikum-Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.ORCID 0000-0002-4499-1673
Nathanael RaschzokDepartment of Surgery, Campus Charité Mitte | Campus Virchow-Klinikum-Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.
Igor M SauerDepartment of Surgery, Campus Charité Mitte | Campus Virchow-Klinikum-Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.
Frank TackeDepartment of Hepatology and Gastroenterology, Campus Charité Mitte | Campus Virchow-Klinikum-Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.ORCID 0000-0001-6206-0226
Pavel StrnadDepartment of Gastroenterology, Metabolic Disorders and Intensive Care, University Hospital RWTH Aachen, 52074 Aachen, Germany.ORCID 0000-0002-7122-6379
Christian TrautweinDepartment of Gastroenterology, Metabolic Disorders and Intensive Care, University Hospital RWTH Aachen, 52074 Aachen, Germany.
Ulf Peter NeumannDepartment of Surgery and Transplantation, University Hospital RWTH Aachen, 52074 Aachen, Germany.
Jiri FronekDepartment of Transplant Surgery, Institute for Clinical and Experimental Medicine, 140 21 Prague, Czech Republic.ORCID 0000-0003-2379-3886
Arianeb MehrabiDepartment of General, Visceral and Transplantation Surgery, University of Heidelberg, 69120 Heidelberg, Germany.
Johann PratschkeDepartment of Surgery, Campus Charité Mitte | Campus Virchow-Klinikum-Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.
Andrea SchlegelThe Liver Unit, Queen Elizabeth Hospital Birmingham, Birmingham B15 2TH, UK.
Georg LurjeDepartment of Surgery and Transplantation, University Hospital RWTH Aachen, 52074 Aachen, Germany.ORCID 0000-0001-9674-0756

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ischemia-reperfusion injury (IRI) constitutes a significant source of morbidity and mortality after orthotopic liver transplantation (OLT). The allograft is metabolically impaired during warm and cold ischemia and is further damaged by a paradox reperfusion injury after revascularization and reoxygenation. Short-term and long-term complications including post-reperfusion syndrome, delayed graft function, and immune activation have been associated with IRI. Due to the current critical organ shortage, extended criteria grafts are increasingly considered for transplantation, however, with an elevated risk to develop significant features of IRI. In recent years, ex vivo machine perfusion (MP) of the donor liver has witnessed significant advancements. Here, we describe the concept of hypothermic (oxygenated) machine perfusion (HMP/HOPE) approaches and highlight which allografts may benefit from this technology. This review also summarizes clinical applications and the main aspects of ongoing randomized controlled trials on hypothermic perfusion. The mechanistic aspects of IRI and hypothermic MP-which include tissue energy replenishment, optimization of mitochondrial function, and the reduction of oxidative and inflammatory damage following reperfusion-will be comprehensively discussed within the context of current preclinical and clinical evidence. Finally, we highlight novel trends and future perspectives in the field of hypothermic MP in the context of recent findings of basic and translational research.

Indexed as

extended criteria donationHOPEhypothermic machine perfusionischemia-reperfusion injurymachine perfusion

Identifiers

PMID32244972
PMCPMC7141496

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.